Comparative Pharmacokinetics and Bioequivalence Evaluation of Two Formulations of Pramipexole Dihydrochloride Extended-Release Tablets in Healthy Chinese Subjects Under Fasted and Fed States: A Randomized, Open-Label, Single-Dose, Two-Period Crossover Clinical Trial
Drug Design, Development and Therapy · 2023
DOI: 10.2147/dddt.s421449 ↗Kurz gefasst
Klinische Studie (Phase I) in der Zeitschrift Drug Design, Development and Therapy, 2023. Verfasst von Ling Yang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, West China Hospital, Sichuan University, Chengdu, People's Republic of China. Hauptthemen laut MEDLINE: East Asian People, Pramipexole, Therapeutic Equivalency, Dopamine Agonists. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, West China Hospital, Sichuan University, Chengdu, People's Republic of China.
- Clinical Trial Center, West China Hospital, Sichuan University, Chengdu, People's Republic of China.
- Department of Pulmonary and Critical Care Medicine, West China Hospital, Sichuan University, Chengdu, People's Republic of China.
ORCID-Profile: Ling Yang
Zitieren
APA
Yang, L., Zhang, L., & Luo, Z. (2023). Comparative Pharmacokinetics and Bioequivalence Evaluation of Two Formulations of Pramipexole Dihydrochloride Extended-Release Tablets in Healthy Chinese Subjects Under Fasted and Fed States: A Randomized, Open-Label, Single-Dose, Two-Period Crossover Clinical Trial. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s421449
Vancouver
Yang L, Zhang L, Luo Z. Comparative Pharmacokinetics and Bioequivalence Evaluation of Two Formulations of Pramipexole Dihydrochloride Extended-Release Tablets in Healthy Chinese Subjects Under Fasted and Fed States: A Randomized, Open-Label, Single-Dose, Two-Period Crossover Clinical Trial. Drug Design, Development and Therapy. 2023. doi:10.2147/dddt.s421449
BibTeX
@article{Yang2023,
author = {Yang, Ling and Zhang, Liangliang and Luo, Zhu},
title = {Comparative Pharmacokinetics and Bioequivalence Evaluation of Two Formulations of Pramipexole Dihydrochloride Extended-Release Tablets in Healthy Chinese Subjects Under Fasted and Fed States: A Randomized, Open-Label, Single-Dose, Two-Period Crossover Clinical Trial},
journal = {Drug Design, Development and Therapy},
year = {2023},
doi = {10.2147/dddt.s421449}
}
EUVIMED